Patents for C12R 1 - Micro-organisms (92,025) |
---|
08/03/1995 | WO1995020398A1 Human growth hormone |
08/03/1995 | WO1995020318A1 Ancient organisms |
08/03/1995 | WO1995017508A3 Glutamate receptor (or eaa receptor) polynucleotides and their uses |
08/03/1995 | WO1995015391A3 Aspergillus expression system |
08/03/1995 | WO1995014038A3 Purification of hemoglobin |
08/03/1995 | CA2182364A1 Microorganisms for biological control of plant diseases |
08/03/1995 | CA2182269A1 Ancient organisms |
08/03/1995 | CA2182206A1 Human dna mismatch repair proteins |
08/03/1995 | CA2182205A1 Human growth hormone |
08/03/1995 | CA2181602A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof |
08/03/1995 | CA2181062A1 Diagnosis of metastatic cancer by the mts-1 gene |
08/03/1995 | CA2180443A1 Novel cell surface receptor, antibody compositions, and methods of using same |
08/03/1995 | CA2159089A1 Coated phaffia rhodozyma yeast and granule thereof |
08/02/1995 | EP0665291A1 Host-vector system for the expression of glucose oxidase |
08/02/1995 | EP0665290A2 Process for gene transfer into plant cells |
08/02/1995 | EP0665289A2 Peptides from GAD65, provoking autoimmune reactions |
08/02/1995 | EP0664834A1 Recombinant humanized anti-cytomegalovirus antibodies |
08/02/1995 | EP0664779A1 Antibiotic agents |
08/02/1995 | EP0664706A1 Protein kinase c inhibition and novel compound balanol |
08/02/1995 | EP0522030B1 Hepatitis b vaccine |
08/02/1995 | CN1106067A Enzymatic hydroxylation process for the preparation HMG-COA reductase inhibitors and intermediates thereof |
08/02/1995 | CN1106066A Biotin biosynthesis in bacillus subtilis |
08/02/1995 | CN1106065A Maltose-trehalose converting enzyme, and preparation and uses thereof |
08/01/1995 | US5437992 Five thermostable xylanases from microtetraspora flexuosa for use in delignification and/or bleaching of pulp |
08/01/1995 | US5437989 Alcohol/aldehyde dehydrogenase from Gluconobacter oxydans DSM 4025 FERM BP-3812 |
08/01/1995 | US5437986 Ferementing bacteria in broth, disrupting and cooling; adding acid and incubating to inactivate bacteria to inhibit emission of live bacteria while centrifuging; increased purity |
08/01/1995 | US5437974 DNA sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
08/01/1995 | US5437951 A genetic construct comprising a PAPILLOMAVIRUS L1 gene; vaccines, diagnostic kits; genetic engineering |
08/01/1995 | US5437865 Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium |
08/01/1995 | US5437864 Removing blood from patient, administering a monoclonal antibody to neutralization |
08/01/1995 | CA2037043C Process for the preparation of d-pantolactone |
08/01/1995 | CA1336509C Polypeptide possessing isoamylase activity, and its uses |
07/29/1995 | CA2140698A1 Expression system, integration vector and cell modified by said vector |
07/27/1995 | WO1995020047A2 Production of acariogenic sugar substitutes |
07/27/1995 | WO1995020040A1 Pseudomonas biocontrol strains |
07/27/1995 | WO1995020039A2 Customized proteases with altered transacylation activity |
07/27/1995 | WO1995019993A1 Protein kinases |
07/27/1995 | WO1995019988A1 Materials and methods relating to proteins that interact with casein kinase i |
07/27/1995 | WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
07/27/1995 | WO1995019771A1 Indole diterpene alkaloid compounds |
07/27/1995 | WO1995017511A3 Mycobacteria virulence factors and a method for their identification |
07/27/1995 | WO1995014778A3 Dna sequence coding for a bmp receptor |
07/27/1995 | WO1995010616A3 USE OF α-1,4-GLUCAN LYASE FOR PREPARATION OF 1,5-D-ANHYDROFRUCTOSE |
07/27/1995 | CA2181371A1 Indole diterpene alkaloid compounds |
07/27/1995 | CA2174525A1 Customized proteases with altered transacylation activity |
07/27/1995 | CA2158749A1 Materials and methods relating to proteins that interact with casein kinase i |
07/26/1995 | EP0664450A1 Biotest |
07/26/1995 | EP0664337A1 Methods for utilizing cell lines which lack human class II histocompatibility antigens |
07/26/1995 | EP0664336A1 Saccharomyces specific antigenes and antibodies, their preparation and their use |
07/26/1995 | EP0663957A1 Fermentative method of preparing 2-hydroxyphenylacetic acid. |
07/26/1995 | EP0663956A1 Dna sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants |
07/26/1995 | EP0663953A1 Phagemids coexpressing a surface receptor and a surface heterologous protein |
07/26/1995 | EP0663950A1 Cellulase variants |
07/26/1995 | EP0663949A1 New xylanases having high activity and stability at alkaline conditions and high temperatures |
07/26/1995 | EP0522036B1 BACILLUS THURINGIENSIS cryIIIC GENE AND PROTEIN TOXIC TO COLEOPTERAN INSECTS. |
07/26/1995 | EP0167616B1 Cytokeratin tumor markers and assays for their detection |
07/26/1995 | CA2140988A1 Saccharomyces-specific antigens and antibodies, their preparation and use |
07/25/1995 | US5436318 Hepatitis C virus epitopes |
07/25/1995 | US5436231 Hypertensive agents |
07/25/1995 | US5436169 Protein associated with acute pancreatitis agents for the screening of acute pancreatitis |
07/25/1995 | US5436162 Human manganese superoxide dismutase (hMn-SOD) |
07/25/1995 | US5436159 Enzyme genes and yeasts |
07/25/1995 | US5436158 Rhizopus host vector system |
07/25/1995 | US5436157 Human intra-acrosomal sperm antigen |
07/25/1995 | US5436155 Isolated DNA encoding a somatostatin receptor |
07/25/1995 | US5436154 Stable hybridoma cells and antigen-antibodies |
07/25/1995 | US5436150 Inserted mutants into Dna sequences |
07/25/1995 | US5436145 Process for preparing 6-hydroxy nitrogen-containing 6-membered ring compounds |
07/25/1995 | US5436141 Method for synthesizing stable single-stranded CDNA in eukaryotes by means of a bacterial retron and products |
07/25/1995 | US5436139 Non-passageable virus |
07/25/1995 | US5436138 Method for protein N-myristoylation |
07/25/1995 | US5436136 Repressible yeast promoters |
07/25/1995 | US5436002 Bacillus thuringiensisisolate PS201T6 toxin |
07/25/1995 | CA1336416C Production of human serum albumin by fermentation |
07/25/1995 | CA1336414C D-amidase and process for producing d--alanine and/or l--alanineamide |
07/25/1995 | CA1336407C Prevention and treatment of retroviral disease |
07/25/1995 | CA1336391C Fungicidal toxin and method and inoculum for controlling root rot and damping off |
07/23/1995 | CA2140703A1 Biotest |
07/21/1995 | CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use |
07/20/1995 | WO1995019442A1 Production of l-isoleucine by means of recombinant micro-organisms with deregulated threonine dehydratase |
07/20/1995 | WO1995019440A1 Enzyme based bioremediation |
07/20/1995 | WO1995019438A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
07/20/1995 | WO1995019436A1 Mammalian monocyte chemoattractant protein receptors |
07/20/1995 | WO1995019435A2 T cell antigen receptor v region proteins and methods of preparation thereof |
07/20/1995 | WO1995019433A2 Anti-hepatitis b poly- and oligonucleotides |
07/20/1995 | WO1995019432A1 Cell lines, maturation factors and use of said cell lines and factors |
07/20/1995 | WO1995019427A1 Purification of retroviral vectors |
07/20/1995 | WO1995019425A1 Bacterial strains of genus bacillus closely phenotypically related to genus lactobacillus, culture method and use |
07/20/1995 | WO1995019374A1 Bacterial receptor structures |
07/20/1995 | WO1995019371A2 Expression of surface layer proteins |
07/20/1995 | WO1995019363A1 Antiparasitic pyrrolobenzoxazine compounds |
07/20/1995 | WO1995019183A1 Cd44 expression in smooth muscle cells |
07/20/1995 | DE19500723A1 New variable domains of antibody recognising cancer specific mucin |
07/20/1995 | CA2181347A1 Cell lines, maturation factors and use of said cell lines and factors |
07/20/1995 | CA2181171A1 T cell antigen receptor v region proteins and methods of preparation thereof |
07/20/1995 | CA2181159A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
07/20/1995 | CA2181066A1 Purification of retroviral vectors |
07/20/1995 | CA2180934A1 Enzyme based bioremediation |
07/20/1995 | CA2180347A1 Anti-hepatitis b poly- and oligonucleotides |
07/20/1995 | CA2179391A1 Cd44 expression in smooth muscle cells |